Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial, shares soar
(Reuters) – Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a...
Read More
Updated
Hitting cancer early: AstraZeneca’s bid to outmaneuver rivals
By Ben Hirschler LONDON (Reuters) – AstraZeneca <AZN.L> suffered its biggest daily...
Read More
Europe recalls generic heart drug made in China on cancer fears
LONDON (Reuters) – A number of high blood pressure and heart drugs containing an ingredient...
Read More
AbbVie wins reversal of $140 million verdict in case over AndroGel risks
By Nate Raymond (Reuters) – A U.S. judge on Thursday overturned a $140.1 million verdict...
Read More
Johns Hopkins Hospital in Baltimore evacuated due to possible TB exposure
WASHINGTON (Reuters) – Two buildings at the Johns Hopkins Hospital in Baltimore, Maryland,...
Read More
Timeline: Britain’s National Health Service turns 70
LONDON (Reuters) – Britain marks the 70th anniversary of the founding of the National Health...
Read More
Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic
By Michael Erman and Caroline Humer NEW YORK (Reuters) – In the escalating battle over U.S....
Read MoreTrump administration names new U.S. drug enforcement chief
(Refiles this July 2 story to correct typo in name of former President George W. Bush in paragraph 7.) (Reuters) – The Trump administration on Monday named a top White House lawyer as the new head of the U.S. Drug...
Read More
Britain moves closer to legalizing medicinal use of cannabis
By Andrew MacAskill LONDON (Reuters) – Britain moved a step closer to legalizing the...
Read More
Sanofi beefs up diabetes pipeline to retrieve success
By Matthias Blamont PARIS (Reuters) – Sanofi sees a more diversified pipeline driving a...
Read More
Roche ‘highly encouraged’ by Tecentriq results in breast cancer
ZURICH (Reuters) – Swiss drugmaker Roche said on Monday that a trial showed its...
Read More
Britain’s health service has started planning for Brexit no deal
LONDON (Reuters) – Britain’s public health service has started “significant...
Read More
Missouri appeals court tosses $55 million J&J talc-powder verdict
By Tina Bellon (Reuters) – A Missouri appeals court on Friday threw out a $55 million...
Read More
AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge
By Nate Raymond (Reuters) – A U.S. judge on Friday found that pharmaceutical company AbbVie...
Read MoreIowa’s top court rejects waiting period for abortions
(Reuters) – Iowa’s Supreme Court on Friday rejected a 72-hour waiting period for abortions signed into law last year, ruling it unconstitutional. Iowa, which separately in April passed the nation’s strictest...
Read MoreFDA approves Pulmonx’s valve to treat lung disease
By Sharnya G and Anuron Kumar Mitra (Reuters) – The U.S. Food and Drug Administration on Friday approved Pulmonx Inc’s valve to treat a severe form of obstructive lung disease, most often characterized by shortness...
Read More
Rival Novartis, Gilead CAR-T therapies win European panel recommendation
By John Miller ZURICH (Reuters) – Rival cancer cell therapies from Swiss drugmaker Novartis...
Read More
FDA approves Dermira’s wipe for excessive armpit sweating
By Manas Mishra and Sharnya G (Reuters) – Dermira Inc <DERM.O> said on Friday its...
Read MoreIndivior gets breather after court extends order blocking generic rival
By Justin George Varghese (Reuters) – Indivior Plc got a breather on Friday as a U.S. court extended a restraining order blocking a rival from launching a generic version of its bestselling opioid addiction treatment in...
Read More
U.S. coal industry needs ‘fundamental shift’ to fight black lung: report
By Valerie Volcovici WASHINGTON (Reuters) – Coal companies need to make a “fundamental...
Read More